Physician profile
Justin Robbins
NPI 1578547915
$7,850.94
in general payments reported to CMS, 2019-2025
8 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,017 · 2020: $61.44 · 2021: $41.96 · 2022: $103 · 2023: $2,171 · 2024: $98.82 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $975 · Food and Beverage: $875 · Travel and Lodging: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $974.60 |
| Food and Beverage | $874.57 |
| Travel and Lodging | $778.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,818.12 | 2019-2025 | Inbone, Infinity, Prostep |
| Medinc of Texas | $2,248.79 | 2019 | |
| Arthrex, INC. | $1,685.00 | 2019 | |
| Wright Medical Technology, INC. | $1,039.39 | 2019 | |
| Davol INC. | $19.05 | 2024 | Arista Ah Flexitip |
| Boston Scientific Corporation | $14.38 | 2021 | |
| Kerecis Limited | $13.77 | 2022 | |
| Vericel Corporation | $12.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Robbins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.